⌘K

Login Start Free

Home/Filings/4/0001415889-25-023997

4//SEC Filing

KANTOFF AARON 4

Accession 0001415889-25-023997

CIK 0001827506other

View on SEC.gov Company Profile

Filed

Sep 8, 8:00 PM ET

Accepted

Sep 9, 6:00 PM ET

Size

10.5 KB

Accession

0001415889-25-023997

Insider Transaction Report

Form 4

Period: 2025-09-05

Tourmaline Bio, Inc.TRML

Director

Transactions

Exercise/Conversion
Common Stock
2025-09-05$0.13/sh+37,890$4,926→ 83,281 total
Exercise/Conversion
Common Stock
2025-09-05$9.46/sh+10,000$94,600→ 93,281 total
Exercise/Conversion
Stock Option (Right to Buy)
2025-09-05−37,890→ 0 total
Exercise: $0.13Exp: 2033-02-02→ Common Stock (37,890 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2025-09-05−10,000→ 0 total
Exercise: $9.46Exp: 2033-10-22→ Common Stock (10,000 underlying)

Footnotes (1)

[F1]The shares subject to the option are fully vested and immediately exercisable.

Documents

1 file

4
form4-09092025_060901.xmlPrimary

Issuer

Tourmaline Bio, Inc.

CIK 0001827506

Entity typeother

Related Parties

1

filerCIK 0001862734

Filing Metadata

Form type: 4
Filed: Sep 8, 8:00 PM ET
Accepted: Sep 9, 6:00 PM ET
Size: 10.5 KB

View on SEC.gov